2002
DOI: 10.1007/978-1-4615-0193-0_82
|View full text |Cite
|
Sign up to set email alerts
|

Enzyme Immunoassays for 15-F2t Isoprostane-M, an Urinary Biomarker for Oxidant Stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 5 publications
0
8
0
Order By: Relevance
“…Urine samples were analyzed for 8‐isoPGF levels using a competitive ELISA (OxisResearch, Portland, OR) (Sasaki et al ). Briefly, samples were mixed with an enhancing reagent to eliminating interference due to non‐specific binding.…”
Section: Methodsmentioning
confidence: 99%
“…Urine samples were analyzed for 8‐isoPGF levels using a competitive ELISA (OxisResearch, Portland, OR) (Sasaki et al ). Briefly, samples were mixed with an enhancing reagent to eliminating interference due to non‐specific binding.…”
Section: Methodsmentioning
confidence: 99%
“…Other interfering contaminants may be released from solid phase cartridges or from plastics used in the assay [12]. Studies comparing the values obtained by immunoassay and GC/MS measurements have shown very different results depending on the antibodies used, the extent of sample purification, and the fluid measured, with some studies finding excellent correlation [10, 13, 14] and other finding either modest [15] or very poor correlation [16-18]. Because of the poorer precision of immunoassays, larger numbers of subjects may be required to detect significant differences between populations when using immunoassays than when using mass spectrometric assays and validation by mass spectrometry of the results obtained by immunoassay, at least in a subset of samples, improves confidence in the overall conclusions.…”
Section: Measuring Lipid Peroxidation In Vivomentioning
confidence: 99%
“…Although there are commercial immunoassay kits for measuring F 2 -isoprostanes, the reliability of some of these methods has been questioned. For example, some authors report a strong correlations between GC-MS F 2 -isoprostane values and values obtained by immunoassay (Basu, 1998; Sasaki et al, 2002), whereas others report significant but relatively weak correlations (i.e., r = .62, p < .02) between the two methods (Proudfoot et al, 1999). Therefore, future work is required to determine whether immunoassays for F 2 -isoprostanes can reach the sensitivity and reliability of the well-established GC-MS methods.…”
Section: Biomarkers Of Oxidative Damagementioning
confidence: 99%